November 13, 2024
Medacta’s Unveiling of GMK SpheriKA Continues Across Europe, Featuring Innovative Personalized Solutions at SIOT 2024 in Italy
CASTEL SAN PIETRO, 13 November 2024 - Medacta Group SA (“Medacta”, SIX:MOVE), is pleased to announce the presentation of GMK SpheriKA, the first femoral component for total knee replacement optimized for kinematic alignment at the SIOT 2024 Conference in Rome, Italy, on October 29-31. The launch events featured contributions from esteemed faculty members, who shared their expertise and insights on the Kinematic Alignment technique and the GMK SpheriKA implant.
"There is an increasing interest within the scientific community regarding kinematic alignment, driven by its potential to significantly enhance patient outcomes and satisfaction," commented Dr. Adravanti after the launch event.
Despite the excellent longevity of total knee arthroplasty (TKA), many patients continue to experience functional deficits after surgery. Patient expectations are not as well fulfilled by TKA as by total hip replacement, with fewer knee patients achieving a “forgotten joint” replacement. Studies show that around 20% of TKA patients are not satisfied [1, 2, 3]. In response to these challenges, the Kinematic Alignment technique, initially developed in collaboration with Dr. Howell, has emerged as a proven solution for shortening this clinical gap: several peer-reviewed studies have shown it to improve patient outcomes [4, 5, 6]. It enables the surgeon to restore the natural knee shape and specific knee alignment based on the patient's unique anatomy without the need for ligament release.
Highlighting the significance of this development, Prof. Bellemans stated, “We are today witnessing a historical revolution in knee arthroplasty, where implants have now become available that are compatible with the restoration of the patient’s native geometry and kinematics!”.
At the events, attendees had the opportunity to learn more about GMK SpheriKA. Built upon the legacy of the GMK Sphere's Ball-in-Socket design, which was based on the knee anatomy and kinematic studies conducted by Prof. Michael Freeman and Prof. Vera Pinskerova[7], GMK SpheriKA offers patients an implant that potentially feels more natural and stable during daily activities, replicating the movement of the healthy knee. GMK SpheriKA is the first knee system specifically designed based on the principles of Kinematic Alignment, which allows surgeons to better accommodate optimal patella tracking in a wider range of patients.
Emphasizing the potential impact of this combination, Dr. Madonna added: “Preliminary results and patient outcomes with GMK SpheriKA and the Kinematic Alignment technique are extremely promising. This combination may significantly enhance patient satisfaction and functional outcomes after knee replacement surgery. “
GMK SpheriKA is part of MyKA, Medacta's complete platform for Kinematic Alignment. This innovative system provides surgeons with the most comprehensive tools and techniques to perform KA procedures with precision and confidence.
Underscoring the biomechanical advantages of this approach, Prof. Victor said, “Integrated medial stability with biomimetic kinematic performance is the natural solution to the long-standing total knee enigma: how to recreate physiologic ligament loading in the resurfaced knee joint.”
In addition, Medacta showcased the NextAR Augmented Reality Surgical Platform, which leverages patient-specific, unique, real-time data to efficiently complement the operative workflow, enabling data-driven decision-making based on each patient's unique anatomy and biomechanics. NextAR is offered as a hardware system with limited capital investment and single-use instrumentation at a low cost per case and offers the ability to host software for multiple applications. NextAR is part of the MySolutions Personalized Ecosystem, a network of advanced digital solutions designed to improve patient outcomes and healthcare efficiency during the entire episode of care.
All Medacta products, including GMK SpheriKA and NextAR, are supported by the comprehensive, tailored educational offerings provided by the M.O.R.E. Institute. With an international network of expert surgeons, the M.O.R.E. Institute is at the forefront of education with personalized, high-level educational pathways. With Medacta, the surgeon is never alone.
A special thank you to the esteemed faculty members P. Andravanti, J. Bellemans, S. Campi, E. Franceschetti, V. Madonna, M. Malavolta, L. Sabatini, F. Traina, C. Sosio, and J. Victor for their invaluable contributions and insights that enriched our discussions at the SIOT 2024 Conference.
Medacta showcased its innovative GMK SpheriKA knee implant at several European Congresses, including the SOFCOT Congress held in Paris from November 11-13, 2024. On November 12, a dedicated launch event took place featuring presentations by Dr. Sappey-Marinier and Dr. Marchetti. The two experts shared their insights and preliminary findings on Kinematic Alignment in synergy with the GMK SpheriKA implant.
CONTACT
Gianluca Olgiati
Group Vice President Marketing
+41 91 696 60 60
media@medacta.ch
ABOUT MEDACTA
Medacta is a global key player specializing in the design, production, and distribution of innovative, personalized, and sustainable solutions for joint replacement, sports medicine, and spine surgery. Established in 1999 in Switzerland, Medacta is committed to improving the care and well-being of patients and maintains a strong focus on healthcare sustainability. Through close collaboration with expert surgeons globally, continuous investments in R&D, and the adoption of cutting-edge technologies, Medacta’s innovation prioritizes minimally invasive surgery and personalized solutions for every patient. Through the M.O.R.E. Institute, Medacta supports surgeons with a comprehensive and tailored program dedicated to the advancement of medical education. Medacta is headquartered in Castel San Pietro, Switzerland, and operates in over 60 countries. Follow us on Medacta TV, YouTube, LinkedIn and X.
RELATED TRADEMARKS
Medacta Group Related Trademarks are registered at least in Switzerland. The products and services listed below may not be all-inclusive, and other Medacta products and services not listed below may be covered by one or more trademarks. The below products and services may be covered by additional trademarks not listed below. Note that Swiss trademarks may have foreign counterparts. MySolutions™ Personalized Ecosystem, NextAR™, GMK® Sphere, GMK®SpheriKA, MyKA™.
REFERENCES
[1] Bourne RB et al. “Patients satisfaction after total knee arthroplasty: who is satisfied and who is not?” Clin Orthop Relat Res, 2010.
[2] Tippett SR et al. “Collecting Data with Palm Technology: Comparing Preoperative Expectations and Postoperative Satisfaction in Patients Undergoing Total Knee Arthroplasty “ J Bone Joint Surg Am. 2010.
[3] Behrend et al.” The “Forgotten Joint” as the Ultimate Goal in Joint Arthroplasty”, The Journal of Arthroplasty vol 27, n 3, 2012.
[4] Van Essen, James, et al. "Kinematic alignment results in clinically similar outcomes to mechanical alignment: Systematic review and meta-analysis." The Knee 40 (2023): 24-41.
[5] Roussot, Mark Anthony, Georges Frederic Vles, and Sam Oussedik. "Clinical outcomes of kinematic alignment versus mechanical alignment in total knee arthroplasty: a systematic review." EFORT open reviews 5.8 (2020): 486-497.
[6] Blakeney, W., Clément, J., Desmeules, F. et al. Kinematic alignment in total knee arthroplasty better reproduces normal gait than mechanical alignment. Knee Surg Sports Traumatol Arthrosc 27, 1410–1417 (2019).
[7] Freeman MAR, Pinskerova V “The movement of the normal tibio-femoral joint”, J Biomech. 2005 Feb;38(2):197-208